NCT05172934View on ClinicalTrials.gov

Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

September 12, 2023

Study Completion Date

November 1, 2023

Conditions
Ischemic Stroke
Interventions
DRUG

intra-arterial tenecteplase

intra-arterial drug administered after mechanical thrombectomy

Trial Locations (1)

43606

ProMedica Toledo Hospital, Toledo

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

ProMedica Health System

OTHER

NCT05172934 - Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial | Biotech Hunter | Biotech Hunter